Clinical Trials Directory

Trials / Unknown

UnknownNCT06148220

A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Huashan Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of this study was to establish and optimize the \[18F\]RCCB6 and \[68Ga\]Ga-NOTA-RCCB6 PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy of the above imaging agents in renal cancer (especially clear cell renal cell carcinoma) and lymphoma was evaluated.

Conditions

Interventions

TypeNameDescription
RADIATION[18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT imagingIntravenous injection of 3.7 MBq \[0.1 mCi\]/kg of \[18F\]RCCB6 or \[68Ga\]Ga-NOTA-RCCB6 in a single dose

Timeline

Start date
2023-10-01
Primary completion
2024-06-13
Completion
2024-09-01
First posted
2023-11-28
Last updated
2024-02-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06148220. Inclusion in this directory is not an endorsement.